Macrobid Dosing for UTI
For uncomplicated cystitis in adults, nitrofurantoin monohydrate/macrocrystals (Macrobid) 100 mg twice daily for 5 days is the recommended first-line treatment. 1
Adult Dosing
Standard Regimen for Uncomplicated Cystitis
- Dose: 100 mg orally twice daily
- Duration: 5 days 1
- Administration: Take with food to increase bioavailability by approximately 40% 2
The FDA label indicates 7 days of therapy 2, but clinical trial data demonstrates that 5 days is equally effective and is the guideline-recommended duration 1. The 5-day regimen achieves 90% clinical cure rates and 92% microbiological cure rates, equivalent to trimethoprim-sulfamethoxazole 1.
Why Nitrofurantoin is First-Line
Nitrofurantoin is prioritized because it:
- Has minimal resistance rates (88-93% clinical cure, 86-92% bacterial cure) 1
- Causes minimal collateral damage to gut and other microbiomes 1
- Maintains high urinary concentrations while keeping serum levels low 2
- Demonstrates superior efficacy to single-dose fosfomycin (70% vs 58% clinical resolution at 28 days) 3
Pediatric Dosing
For children over 12 years: 100 mg twice daily for 7 days 2
For children under 12 years, nitrofurantoin monohydrate/macrocrystals is not the standard formulation; other nitrofurantoin preparations with weight-based dosing should be used.
Renal Function Considerations
Critical Caveat on Renal Dosing
The FDA label contraindicates nitrofurantoin when creatinine clearance (CrCl) is <60 mL/min 2. However, this contraindication lacks robust clinical evidence and appears based on outdated pharmacokinetic data from 1968 that measured urinary excretion rather than urinary concentrations or clinical outcomes 4.
Recent evidence suggests nitrofurantoin can be used safely and effectively with CrCl ≥30 mL/min:
- Clinical cure rates are equivalent in patients with CrCl 30-60 mL/min compared to >60 mL/min (no significant difference) 5
- A large population study showed similar treatment failure rates across renal function groups 6
- Available data support considering use with CrCl ≥40 mL/min at minimum 4
Do not use nitrofurantoin when:
- CrCl <30 mL/min (insufficient data and genuine concern for inadequate urinary concentrations)
- Suspected pyelonephritis (inadequate tissue penetration due to low serum levels)
Alternative Agents
When Nitrofurantoin Cannot Be Used
First alternatives:
- Trimethoprim-sulfamethoxazole 160/800 mg twice daily for 3 days - only if local resistance rates <20% 1
- Fosfomycin 3 g single dose - inferior efficacy (58% vs 70% with nitrofurantoin) but acceptable when other options unavailable 1, 3
Second-line alternatives:
- Fluoroquinolones (ciprofloxacin, levofloxacin) for 3 days - highly effective but reserve for more serious infections due to collateral damage concerns 1
- Beta-lactams (amoxicillin-clavulanate, cefdinir, cefpodoxime) for 3-7 days - use only when other agents cannot be used; inferior efficacy and more adverse effects 1
Never use empirically:
- Amoxicillin or ampicillin alone (high resistance rates, poor efficacy) 1
For Multidrug-Resistant Organisms
- VRE uncomplicated UTI: Nitrofurantoin 100 mg every 6 hours (note: four times daily dosing for VRE) 7
- CRE simple cystitis: Single-dose aminoglycoside 7
Common Pitfalls to Avoid
Don't extend to 7 days routinely - 5 days is equally effective with less antibiotic exposure 1, 8
Don't avoid in mild-moderate renal dysfunction - The CrCl <60 mL/min contraindication is not evidence-based; consider using down to CrCl 30-40 mL/min 6, 4, 5
Don't use for pyelonephritis - Low serum/tissue levels make it inappropriate for upper tract infections 2
Don't prescribe without food - Bioavailability increases 40% when taken with meals 2
Avoid in patients with cirrhosis or benign prostatic hyperplasia - Associated with decreased clinical cure rates 5
Adverse Effects
Most common side effects are nausea (3%) and headache 1. Serious pulmonary and hepatic reactions are rare and typically associated with prolonged use, not short-course therapy 4. The 100 mg daily prophylactic dose (different indication) shows higher rates of cough, dyspnea, and nausea compared to 50 mg 9.